Literature DB >> 9013988

Local-clonal expansion of infiltrating T lymphocytes in chronic encephalitis of Rasmussen.

Y Li1, A Uccelli, K D Laxer, M C Jeong, H V Vinters, W W Tourtellotte, S L Hauser, J R Oksenberg.   

Abstract

Rasmussen's syndrome is a progressive and intractable form of epilepsy characterized pathologically by focal brain inflammation with large numbers of infiltrating T lymphocytes. To better understand the nature of the T cell response in this disease, we analyzed TCR expression in the brain lesions using PCR for quantitative assessment of TCRBV gene transcripts, together with size and sequence analysis of the third complementarity-determining region (CDR3) of the dominant TCR rearrangements. Restricted (oligoclonal) BV family usage was not observed, as all of the 22 BV PCR products were usually detected at levels exceeding the background. However, significant individual biases in the frequencies of different TCR families was evident. The distinct pattern of BV expression by infiltrating lymphocytes detected in the original PCR screening suggested a specific immune response. The primary structure of the rearranged CDR3 sequences for the BV family expressed at highest level in each sample was studied by size and sequence analysis. The data showed that predominant TCR BV families expressed in diseased brain tissue displayed limited size heterogeneity and extensive repetition of in-frame CDR3 nucleotide motifs. These findings demonstrate that the local immune response in Rasmussen's syndrome includes restricted T cell populations that have likely expanded from a few precursor T cells responding to discrete antigenic epitopes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9013988

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Humanized mouse model of Rasmussen's encephalitis supports the immune-mediated hypothesis.

Authors:  Hania Kebir; Lionel Carmant; François Fontaine; Kathie Béland; Ciprian M Bosoi; Nathalie T Sanon; Jorge I Alvarez; Sébastien Desgent; Camille L Pittet; David Hébert; Marie-Josée Langlois; Rose-Marie Rébillard; Dang K Nguyen; Cécile Cieuta-Walti; Gregory L Holmes; Howard P Goodkin; John R Mytinger; Mary B Connolly; Alexandre Prat; Elie Haddad
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

Review 2.  [Recent insights into Rasmussen encephalitis].

Authors:  C G Bien; C E Elger
Journal:  Nervenarzt       Date:  2005-12       Impact factor: 1.214

3.  Oligoclonal T cells are infiltrating the brains of children with AIDS: sequence analysis reveals high proportions of identical beta-chain T-cell receptor transcripts.

Authors:  W L Lin; J E Fincke; L R Sharer; D S Monos; S Lu; J Gaughan; C D Platsoucas; E L Oleszak
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

4.  Rasmussen encephalitis and comorbid autoimmune diseases: A window into disease mechanism?

Authors:  Dina Amrom; Demet Kinay; Yvonne Hart; Samuel F Berkovic; Ken Laxer; Frederick Andermann; Eva Andermann; Amit Bar-Or
Journal:  Neurology       Date:  2014-08-20       Impact factor: 9.910

5.  Presence of oligoclonal T cells in cerebrospinal fluid of a child with multiphasic disseminated encephalomyelitis following hepatitis A virus infection.

Authors:  E L Oleszak; W L Lin; A Legido; J Melvin; H Hardison; B E Hoffman; C D Katsetos; C D Platsoucas
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

6.  Characterization of ionotropic glutamate receptors in human lymphocytes.

Authors:  G Lombardi; C Dianzani; G Miglio; P L Canonico; R Fantozzi
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

Review 7.  Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.

Authors:  Yoshiyuki Akiyama; Yi Luo; Philip M Hanno; Daichi Maeda; Yukio Homma
Journal:  Int J Urol       Date:  2020-04-04       Impact factor: 3.369

Review 8.  Encephalitis and epilepsy.

Authors:  Jan Bauer; Christian G Bien
Journal:  Semin Immunopathol       Date:  2009-09-11       Impact factor: 9.623

Review 9.  Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.

Authors:  Mia Levite
Journal:  J Neural Transm (Vienna)       Date:  2014-08-01       Impact factor: 3.575

10.  A case of Rasmussen encephalitis treated with rituximab.

Authors:  Barbara Thilo; Robert Stingele; Karina Knudsen; Rainer Boor; Christian G Bien; Günther Deuschl; Nicolas Lang
Journal:  Nat Rev Neurol       Date:  2009-08       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.